Annual report pursuant to Section 13 and 15(d)

Derivative Financial Instruments and Fair Value - Schedule of Changes in Liabilities with Level 3 of Fair Value (Details)

v3.20.1
Derivative Financial Instruments and Fair Value - Schedule of Changes in Liabilities with Level 3 of Fair Value (Details) - USD ($)
 12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Derivative Instruments and Hedging Activities Disclosure [Abstract]    
Beginning balance $ 350,260 $ 12,435,250
Gain on change in fair value of debentures and warrants (15,167,335) [1]
Fair value of warrants exercised (4,619,150)
Fair value of debentures converted (1,408,901)
Fair value of debentures exchanged for Series I-2 Preferred Stock (1,420)
Modification of warrants 8,603,069
Convertible debt 508,747
Change in fair value of debentures 105,076
Ending balance $ 455,336 $ 350,260
[1] In addition to the gain on change in fair value of debentures and warrants of $15.2 million during the year ended December 31, 2018, the Company recorded a loss on the exchange of convertible debentures into shares of its Series I-2 Preferred Stock of approximately $1.5 million, as more fully discussed in Note 13. Therefore, the total change in the fair value of derivative instruments for the year ended December 31, 2018 was a net gain of $13.7 million.